OmniGuide raises $15M for BeamPath surgical laser

September 26, 2013 by Brad Perriello

OmniGuide Surgical says it raised a $15 million funding round for its BeamPath surgical laser, saying it plans to use the cash to boost its commercialization efforts.

OmniGuide raises $15M for surgical laser

OmniGuide Surgical said it raised a $15 million funding round for its BeamPath surgical layer.

The Cambridge, Mass.-based medical device company said it plans to use the round to expand BeamPath's footprint in the gynecological market and launch new ear, nose & throat products.

"This financing allows us to accelerate the commercialization of our advanced energy surgical products for the operating room," president & CEO Scott Flora said in prepared remarks. "We are excited to have the continued commitment and confidence of such a high quality group of investors – all of whom have been on board with us through numerous growth phases. We look forward to significantly advancing our commercial footprint with this new funding."

Sign up to get our free newsletters delivered straight to your inbox

Prior backers including Stata Venture Partners, Argonaut and Electro Scientific Industries participated in the round, according to the release.

The BeamPath technology, developed at the Mass. Institute of Technology by co-founder Yoel Fink, allows photons from a CO2 laser to glide through the hollow core of OmniGuide's proprietary fiber. The hollow core means there's no medium for the laser to travel through, increasing the wavelengths the fibers transfer and creating a more precise beam. At a mere tens of microns wide, the beam is able to pass through flexible conduits into previously inaccessible areas of the body.